Preparing For A Hybrid J.P. Morgan Healthcare Conference

For nearly 40 years, the annual J.P. Morgan Healthcare Conference (JPM) has been one of the biggest annual get togethers for the biopharmaceutical industry. As such, people spent months, if not years, in preparation. Then COVID-19 came along, and in 2021 we found we had to gear up to attend virtually, which, for the most part, turned out better than most expected. But 2022 brings a new challenge, with JPM moving to a hybrid model, with some people attending in person, and others virtually. We were curious how such a change would impact planning. In this latest executive virtual roundtable (EVR), Stephen From, chairman, EyeGate Pharma; Chris Garabedian, CEO, Xontogeny; and Laurie Stelzer, EVP and CFO, Arena Pharmaceuticals, provide perspectives and wisdom on preparing for a hybrid JPM in 2022.